A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension
Clinical trial NCT03504917 · TERMINATED
Trial details
- NCT number
- NCT03504917
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-08
- Primary completion
- 2020-03-04
- Enrollment
- 322
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.